aucubin has been researched along with Alloxan Diabetes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Du, W; Jin, X; Li, J; Lu, X; Ma, B; Ren, C; Wang, X; Wei, J; Zhang, Q | 1 |
| Bao, X; Jin, X; Li, J; Lu, X; Ma, B; Ren, C; Wei, J; Zhang, C; Zhang, N; Zhu, Z | 1 |
| Bai, D; Jiang, H; Lian, X; Ma, L; Ma, Q; Wang, N; Xue, H | 1 |
| Jin, L; Jin, LJ; Li, XY; Lu, YN; Ma, YS; Xia, YQ; Xu, YP; Xue, HY; Zhang, P | 1 |
| Fang, XM; Gao, GZ; Jin, LJ; Lu, YN; Xu, YP; Xue, HY | 1 |
| Jin, L; Jin, LJ; Li, SY; Xu, YP; Xue, HY | 1 |
| Jin, L; Li, D; Lu, Y; Xia, Y; Xu, Y; Xue, H; Zhang, P | 1 |
7 other study(ies) available for aucubin and Alloxan Diabetes
| Article | Year |
|---|---|
Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoribonucleases; Fibrosis; Hepatic Stellate Cells; Inflammasomes; Iridoid Glucosides; Liver Cirrhosis; Mice; Molecular Docking Simulation; NADPH Oxidase 4; Nitrosamines; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidoreductases; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Thioredoxins; Transforming Growth Factor beta1 | 2022 |
Aucubin supplementation alleviate diabetes induced-disruption of blood-testis barrier and testicular damage via stabilizing cell junction integrity.
Topics: Animals; Blood-Testis Barrier; Connexin 43; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Intercellular Junctions; Male; Mice; Molecular Docking Simulation; Semen; Sertoli Cells; Testis | 2023 |
Determination of aucubin by supramolecular solvent-based dispersive liquid-liquid microextraction and UPLC-MS/MS: Application to a pharmacokinetic study in rats with type 1 diabetes.
Topics: Animals; Area Under Curve; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Iridoid Glucosides; Liquid Phase Microextraction; Male; Rats; Rats, Sprague-Dawley; Solvents; Tandem Mass Spectrometry | 2020 |
Aucubin prevents loss of hippocampal neurons and regulates antioxidative activity in diabetic encephalopathy rats.
Topics: Animals; Antioxidants; Brain Diseases; Cognition Disorders; Diabetes Mellitus, Experimental; Glucosides; Hippocampus; Iridoid Glucosides; Iridoids; Lipid Peroxides; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Wistar | 2009 |
Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.
Topics: Animals; Blood Glucose; Body Weight; Brain Diseases, Metabolic; CA1 Region, Hippocampal; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Iridoid Glucosides; Male; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Wistar | 2012 |
Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glucosides; Glutathione Peroxidase; Immunohistochemistry; Insulin-Secreting Cells; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Male; Malondialdehyde; Pancreas; Protective Agents; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase | 2008 |
Neuroprotection of aucubin in primary diabetic encephalopathy.
Topics: Animals; Blotting, Western; Brain Damage, Chronic; Diabetes Complications; Diabetes Mellitus, Experimental; Glucosides; Immunohistochemistry; Iridoid Glucosides; Iridoids; Male; Microscopy, Electron, Transmission; Neuroprotective Agents; Rats; Rats, Wistar | 2008 |